Magellan Health Services To Present At Oppenheimer 23rd Annual Healthcare Conference
Magellan Health Services, Inc. (NASDAQ: MGLN) announced today that
Jonathan Rubin, Chief Financial Officer, will present a general overview
of the Company and discuss its business strategy at the Oppenheimer 23
Magellan Health Services, Inc. (NASDAQ: MGLN) announced today that Jonathan Rubin, Chief Financial Officer, will present a general overview of the Company and discuss its business strategy at the Oppenheimer 23 rd Annual Healthcare Conference on Thursday, December 13, 2012 at 1 p.m. Eastern. The conference will take place at the Waldorf Astoria in New York City. Investors and the public are invited to access the conference audio and presentation materials through Magellan’s investor relations page at www.MagellanHealth.com. Those who plan to access the webcast should log on to the website approximately 15 minutes before the scheduled start time of the conference to register and download and install any necessary software. The audio and presentation materials will be available for one week following the presentation. Those who plan to access the call or webcast are encouraged to read Magellan's Annual Report on Form 10-K for the year ended December 31, 2011, filed with the Securities and Exchange Commission (SEC) on February 28, 2012, and subsequent Quarterly Reports on Form 10-Q, filed with the SEC during 2012 for material information regarding Magellan's operational and financial results, including the section entitled “Risk Factors.” About Magellan Health Services Headquartered in Avon, Conn., Magellan Health Services Inc. is a leading specialty health care management organization with expertise in managing behavioral health, radiology and specialty pharmaceuticals, as well as public sector pharmacy benefits programs. Magellan delivers innovative solutions to improve quality outcomes and optimize the cost of care for those we serve. As of September 30, 2012, Magellan's customers include health plans, employers and government agencies, serving approximately 33.8 million members in our behavioral health business, 17.3 million members in our radiology benefits management segment, and 8 million members in our medical pharmacy management product. In addition, the specialty pharmaceutical segment served 40 health plans and several pharmaceutical manufacturers and state Medicaid Programs. The Company's Medicaid Administration segment served 24 states and the District of Columbia. For more information, visit www.MagellanHealth.com.